Immune response to B19 parvovirus and an antibody defect in persistent viral infection.
B19 parvovirus has been shown to persist in some immunocompromised patients, and treatment with specific antibodies can lead to decreased quantities of circulating virus and hematologic improvement. A defective immune response to B19 parvovirus in these patients was shown by comparison of results us...
שמור ב:
| הוצא לאור ב: | J Clin Invest |
|---|---|
| Principais autores: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Clinical Investigation
1989
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC329767/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2551923/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114274 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|